Sign in

CIK 0001707502

  • Non-accelerated filer
  • Smaller reporting company

Solid Biosciences Inc.

Sign in to watch
Ticker
SLDB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900943402
Phone
+1 617-337-4680
Business address
500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
Former names
Solid Biosciences, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$24,582
in 1 filing, $25K under 10b5-1 plans

Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brooks Gabriel −$25K Chief Medical Officer sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2021-04-01 RA CAPITAL MANAGEMENT, L.P. Director Other acquisition +787,586 $5.53 $4.4M 787,586
2021-04-01 RA CAPITAL MANAGEMENT, L.P. Director Other acquisition +663,720 $5.53 $3.7M 11,580,287
2021-03-23 Koppel Adam Director Grant or award +869,565 $5.75 $5.0M 7,929,918
2021-03-23 PERCEPTIVE ADVISORS LLC Director Purchase +2,608,695 $5.75 $15.0M 13,412,552
2021-03-19 RA CAPITAL MANAGEMENT, L.P. Director Purchase +2,206,685 $5.75 $12.7M 10,916,567
2021-03-12 Morris Carl Ashley Chief Scientific Officer Sale −11,699 $8.84 $103K 287,301
2021-03-12 Morris Carl Ashley Chief Scientific Officer Sale −11,699 $8.85 $103K 275,602
2021-03-12 Schneider Joel Solomon Zev Chief Operating Officer Sale −11,699 $8.84 $103K 280,473
2021-03-12 Schneider Joel Solomon Zev Chief Operating Officer Sale −11,699 $8.84 $103K 268,774
2021-03-02 Keresty Georgia Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2021-03-02 Kahn Clare Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2021-03-02 Schneider Joel Solomon Zev Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +15,000 15,000
2021-03-01 Brennan Erin Powers Chief Legal Officer, Secretary Grant or award · Employee Stock Option (Right to Buy) +325,000 325,000
2021-02-12 Ganot Ilan CEO & President Sale −457 $7.66 $4K 3,026
2021-01-28 Schneider Joel Solomon Zev Chief Technology Officer Sale −3,443 $6.14 $21K 292,172
2021-01-28 Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy Sale −3,473 $6.14 $21K 335,636
2021-01-28 Morris Carl Ashley Chief Scientific Officer Sale −3,459 $6.14 $21K 299,000
2021-01-28 Ganot Ilan CEO & President Sale −10,713 $6.14 $66K 1,199,821
2021-01-27 Schneider Joel Solomon Zev Chief Technology Officer Exercise or conversion +11,500 295,615
2021-01-27 Schneider Joel Solomon Zev Chief Technology Officer Exercise or conversion · Restricted Stock Units −11,500 0

Page 22 of 31 · 604 trades